imatinib mesylate has been researched along with Injuries, Radiation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dmytrenko, IV; Dyagil, IS; Fedorenko, VG; Martina, ZV; Minchenko, ZM; Petrusha, OO; Shlyakhtichenko, TY; Sholoiko, VV; Silayev, YO; Stupakova, ZV; Tovstogan, AO | 1 |
Boralevi, F; Fricain, JC; Sibaud, V; Vigarios, E | 1 |
1 review(s) available for imatinib mesylate and Injuries, Radiation
Article | Year |
---|---|
[Oral toxicity of targeted anticancer therapies].
Topics: Angiogenesis Inhibitors; Benzamides; ErbB Receptors; Glossitis, Benign Migratory; Humans; Hyperpigmentation; Imatinib Mesylate; Indoles; Maxillary Diseases; Molecular Targeted Therapy; Mouth Mucosa; Osteonecrosis; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrimidines; Pyrroles; Radiation Injuries; Radiotherapy; Stomatitis; Stomatitis, Aphthous; Sunitinib; TOR Serine-Threonine Kinases | 2014 |
1 other study(ies) available for imatinib mesylate and Injuries, Radiation
Article | Year |
---|---|
CHRONIC MYELOID LEUKEMIA COURSE IN PERSONS EXPOSED TO IONIZING RADIATION AS A RESULT OF THE CHORNOBYL ACCIDENT.
Topics: Aged; Air Pollutants, Radioactive; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Chernobyl Nuclear Accident; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Drug Resistance, Neoplasm; Emergency Responders; Female; Food Contamination, Radioactive; Fusion Proteins, bcr-abl; Gene Expression; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Prognosis; Radiation Exposure; Radiation Injuries; Radiation, Ionizing; Soil Pollutants, Radioactive; Survival Analysis; Translocation, Genetic; Ukraine | 2020 |